Skip to main content

Industry insights

Publications

NICE evaluations of oncology products with EMA Conditional Marketing Authorisation

Andrew Mumford, David Ringger

An evaluation of the design of clinical trials conducted for rheumatoid arthritis, 2009-2022

Oliver Darlington, Myrtle Greenwood, Adelaide Shaw-Maguire, Imogen Taylor

Modified Delphi research to seek consensus on dRTA disease model, treatment and management

Sarah Coyle, Scott Donald, Andrew Mumford, Joanne Mumford

Evaluation of NICE Severity modifiers

Janice Cheng, Cameron Collins, Andrew Mumford, Imogen Taylor

The global early access programme landscape and its application to cell and gene therapies

William Irvin, Andrew Mumford, Georgia Roberts, Laura Sopeña Alvarez

Cost-effectiveness analysis of using hypoxic stored red blood cells to reduce the frequency of blood transfusions

Alexander Chrysos, Bethany English, Rubimbo Munetsi

Listen to our podcast: Initiation

Working with Initiate | What to expect working with our market access and health economics consultancy | Initiation Podcast

Developing PROMs in rare diseases | A conversation with Benson Chen from MitoCAMB | Initiation Podcast

Insights from the 2023 Reimbursement Radar wrap-up | Initiation Podcast

View more in Spotify

Events & conferences

We attend a number of major conferences and would love to meet you at the events listed below:

ISPOR Barcelona 2024

17th to 20th November 2024

World EPA Congress 2025

5th-6th March 2025

Talks & webinars

As market access and HEOR experts, we are regularly asked to talk at industry events. We’d love to see you in our audience at the following events:

Life Science Access Academy

Putting the A (Accessibility) into DE&I

Tuesday 19th November 2024 13:00 – 14:00 (GMT)

Life Science Access Academy

EUHTA and its Impact on the UK

Thursday 28th November 2024 13:00 – 14:00 (GMT)

Life Science Access Academy

Market Access and the Celtic Nations

Thursday 5th December 2024 13:00 – 14:00 (GMT)